COVID-19 was primarily considered a pulmonary disease with extrapulmonary
manifestations. As the pandemic spread, there has been growing evidence that the disease …

Accumulating scientific and clinical evidence highlighted pathological hyperinflammation as
a cardinal feature of SARS-CoV-2 infection and acute COVID-19 disease. With the …

Hyperinflammation triggered by SARS-CoV-2 is a major cause of disease severity, with
activated macrophages implicated in this response. OP-101, a hydroxyl-polyamidoamine …

The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges
in critical care medicine, including extreme demand for intensive care unit (ICU) resources …

Omicron generally causes milder disease than previous strains of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), especially in fully vaccinated individuals. However …

The severe acute respiratory syndrome-corona virus type 2 (SARS-CoV-2) is the cause of
human coronavirus disease 2019 (COVID-19). Since its identification in late 2019 SARS …

Infectious diseases worldwide affect human health and have important societal impacts. A
better understanding of infectious diseases is urgently needed. In vitro and in vivo infection …

The objective of this study is to describe our COVID-19 patients with herpesviridae
reactivation in the central nervous system (CNS). Four patients were described including two …

Introduction: The coronavirus (COVID-19) has affected millions of people around the world.
COVID-19 patients, particularly those with the critical illness, have coagulation …

We present a panel of central nervous system (CNS) complications associated with
coronavirus disease 2019 (COVID-19) and their clinical characteristics. We aim to …